المؤلفون: Li, Y, Yu, Z, Schenk, M, Lagovsky, I, Illig, D, Walz, C, Rohlfs, M, Conca, R, Muise, AM, Snapper, SB, Uhlig, HH, Zion Garty, B, Klein, C, Kotlarz, D

العلاقة: https://ora.ox.ac.uk/objects/uuid:521f632d-d05b-44d0-a57d-b6a0c373b399Test; https://doi.org/10.1016/j.jaci.2022.09.033Test

الإتاحة: https://doi.org/10.1016/j.jaci.2022.09.033Test
https://ora.ox.ac.uk/objects/uuid:521f632d-d05b-44d0-a57d-b6a0c373b399Test

المؤلفون: Catalano M, Conca R, Petrioli R, Ramello M, Roviello G

المصدر: Cancer Management and Research, Vol Volume 12, Pp 10271-10278 (2020)

مصطلحات موضوعية: irinotecan, oxaliplatin, second line, pancreatic cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://test.dovepress.com/folfox-vs-folfiri-as-second-line-of-therapy-after-progression-to-gemci-peer-reviewed-article-CMARTest; https://doaj.org/toc/1179-1322Test

الوصول الحر: https://doaj.org/article/63ec3935c0ee46808dee23e82ed05400Test

المؤلفون: Ottaviano, M, Curvietto, M, Rescigno, P, Tortora, M, Palmieri, G, Giannarelli, D, Aieta, M, Assalone, P, Attademo, L, Avallone, A, Bloise, F, Bosso, D, Borzillo, V, Buono, G, Calderoni, G, Caputo, F, Cartenì, G, Cavallero, D, Cavo, A, Ciardiello, F, Conca, R, Conteduca, V, De Falco, S, De Felice, M, De Laurentiis, M, De Placido, P, De Placido, S, De Santo, I, De Stefano, A, Della Corte, CM, Di Franco, R, Di Lauro, V, Fabbrocini, A, Federico, P, Festino, L, Giordano, P, Giuliano, M, Gridelli, C, Grimaldi, AM, Lia, M, Marretta, AL, Massa, V, Mennitto, A, Merler, S, Merz, V, Messina, C, Messina, M, Milano, M, Minisini, AM, Montesarchio, V, Morabito, A, Morgillo, F, Mucci, B, Nappi, L, Napolitano, F, Paciolla, I, Pagliuca, M, Parola, S, Pepe, S, Petrillo, A, Piantedosi, F, Piccin, L, Picozzi, F, Pietroluongo, E, Pignata, S, Prati, V, Riccio, V, Rosanova, M, Rossi, A, Russo, A, Salati, M, Santabarbara, G, Sbrana, A, Simeone, E, Silvestri, A, Spada, M, Tarantino, P, Taveggia, P, Tomei, F, Vincenzo, T, Trapani, D, Trojanello, C, Vanella, V, Vari, S, Ventriglia, J, Vitale, MG, Vitiello, F, Vivaldi, C, von Arx, C, Zacchi, F, Zampiva, I, Zivi, A, Daniele, B, Ascierto, PA, SCITO (Società Campana di ImmunoTerapia Oncologica)

المساهمون: Rescigno, Pasquale

مصطلحات موضوعية: SCITO (Società Campana di ImmunoTerapia Oncologica), Humans, Pneumonia, Viral, Coronavirus Infections, Neoplasms, Prevalence, Medical Oncology, Infection Control, Geography, Adult, Italy, Female, Male, Drug Prescriptions, Pandemics, CTLA-4 Antigen, Programmed Cell Death 1 Receptor, Time-to-Treatment, Surveys and Questionnaires, Practice Patterns, Physicians', Oncologists, Betacoronavirus, Antineoplastic Agents, Immunological, B7-H1 Antigen, COVID-19, SARS-CoV-2

وصف الملف: Print; application/pdf

العلاقة: Journal for immunotherapy of cancer, 2020, 8 (2); https://repository.icr.ac.uk/handle/internal/4346Test

الإتاحة: https://doi.org/10.1136/jitc-2020-001154Test
https://repository.icr.ac.uk/handle/internal/4346Test

المؤلفون: Rubatto M., Fava P., Stanganelli I., Ribero S., Pigozzo J., Di Giacomo A. M., Ridolfi L., Tronconi M. C., Trojaniello C., Bersanelli M., Garutti M., Indini A., De Risi I., De Tursi M., Merelli B., Morgese F., Occelli M., Cappellini G. C. A., Poletto S., Fedele D., Brugnara S., Frisinghelli M., Formisano L., Conca R., Tucci M., Russillo M., Ceroni L., Queirolo P., Targato G., Strippoli S., Mandala' M., Guida M., Quaglino P.

المساهمون: Rubatto, M., Fava, P., Stanganelli, I., Ribero, S., Pigozzo, J., Di Giacomo, A. M., Ridolfi, L., Tronconi, M. C., Trojaniello, C., Bersanelli, M., Garutti, M., Indini, A., De Risi, I., De Tursi, M., Merelli, B., Morgese, F., Occelli, M., Cappellini, G. C. A., Poletto, S., Fedele, D., Brugnara, S., Frisinghelli, M., Formisano, L., Conca, R., Tucci, M., Russillo, M., Ceroni, L., Queirolo, P., Targato, G., Strippoli, S., Mandala', M., Guida, M., Quaglino, P.

مصطلحات موضوعية: Discontinuation of immunotherapy, Metastatic melanoma therapy, Real-life study

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37099946; info:eu-repo/semantics/altIdentifier/wos/WOS:000994560100001; volume:187; firstpage:25; lastpage:35; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11391/1566840Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85153403676

الإتاحة: https://doi.org/10.1016/j.ejca.2023.03.020Test
https://hdl.handle.net/11391/1566840Test

المؤلفون: Roviello G., Corona S., Conca R., Petrioli R., Rosellini P., Bonetta A., Aieta M.

المساهمون: Roviello, G., Corona, S., Conca, R., Petrioli, R., Rosellini, P., Bonetta, A., Aieta, M.

مصطلحات موضوعية: chemotherapy, prostate cancer, vinorelbine, Administration, Oral, Aged, 80 and over, Antineoplastic Agents, Phytogenic, Bone Neoplasm, Human, Male, Middle Aged, Neoplasm Staging, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31261590; info:eu-repo/semantics/altIdentifier/wos/WOS:000480733400100; volume:98; issue:26; firstpage:"-"; lastpage:"-"; numberofpages:5; journal:MEDICINE; http://hdl.handle.net/11368/2961382Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069268829; https://journals.lww.com/md-journal/fulltext/2019/06280/Is_there_still_a_place_for_vinorelbine_in_advanced.101.aspxTest

الإتاحة: https://doi.org/10.1097/MD.0000000000016249Test
http://hdl.handle.net/11368/2961382Test
https://journals.lww.com/md-journal/fulltext/2019/06280/Is_there_still_a_place_for_vinorelbine_in_advanced.101.aspxTest

المؤلفون: Roviello G., Corona S., Bozza G., Aieta M., Generali D., Rodriquenz M. G., Mileo A. M., Imperatori M., Ianza A., Conca R., Sobhani N.

المساهمون: Roviello, G., Corona, S., Bozza, G., Aieta, M., Generali, D., Rodriquenz, M. G., Mileo, A. M., Imperatori, M., Ianza, A., Conca, R., Sobhani, N.

مصطلحات موضوعية: c-KIT, FGFR1–4, Lenvatinib, PDGFRα, Renal cell carcinoma, RET, VEGFR1–3, Angiogenesis Inhibitor, Animal, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Everolimu, Human, Kidney Neoplasm, Phenylurea Compound, Protein Kinase Inhibitor, Quinoline, Vascular Endothelial Growth Factor A

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29718721; info:eu-repo/semantics/altIdentifier/wos/WOS:000432689500008; volume:27; issue:5; firstpage:507; lastpage:512; numberofpages:6; journal:EXPERT OPINION ON INVESTIGATIONAL DRUGS; http://hdl.handle.net/11368/2961370Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85047307780

الإتاحة: https://doi.org/10.1080/13543784.2018.1472235Test
http://hdl.handle.net/11368/2961370Test

المؤلفون: Passiglia F, Commendatore O, Vitali M, Conca R

المساهمون: Passiglia F, Commendatore O, Vitali M, Conca R

مصطلحات موضوعية: NSCLC, PD-1, PD-L1, biomarker, cancer immunogenicity, clinical studie, immune checkpoint inhibitor, translational research, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/2-s2.0-85050010879; info:eu-repo/semantics/altIdentifier/wos/WOS:000438052800005; volume:14; firstpage:41; lastpage:60; numberofpages:20; journal:FUTURE ONCOLOGY; http://hdl.handle.net/10447/295576Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85050010879

الإتاحة: https://doi.org/10.2217/fon-2018-0098Test
http://hdl.handle.net/10447/295576Test

المؤلفون: Li, Y, Yu, Z, Schenk, M, Lagovsky, I, Illig, D, Walz, C, Rohlfs, M, Conca, R, Muise, A, Snapper, S, Uhlig, H, Garty, B, Klein, C, Kotlarz, D

المصدر: Journal of Crohn's and Colitis ; volume 17, issue Supplement_1, page i97-i97 ; ISSN 1873-9946 1876-4479

مصطلحات موضوعية: Gastroenterology, General Medicine

الإتاحة: https://doi.org/10.1093/ecco-jcc/jjac190.0074Test
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i97/51509199/jjac190.0074.pdfTest

المؤلفون: Aline Jorquera L., Jan Wilhelm B., Natalia Conca R.

المصدر: Revista chilena de infectología. 39:448-456

مصطلحات موضوعية: Infectious Diseases, Public Health, Environmental and Occupational Health

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::635c8e3da558c8e9c36bc73f8e8301fcTest
https://doi.org/10.4067/s0716-10182022000400448Test

المؤلفون: Roviello G., Gambale E., Giorgione R., Santini D., Stellato M., Fornarini G., Rebuzzi S. E., Basso U., Bimbatti D., Doni L., Nesi G., Bersanelli M., Buti S., De Giorgi U., Galli L., Sbrana A., Conca R., Carella C., Naglieri E., Pignata S., Procopio G., Antonuzzo L.

المساهمون: Roviello, G., Gambale, E., Giorgione, R., Santini, D., Stellato, M., Fornarini, G., Rebuzzi, S. E., Basso, U., Bimbatti, D., Doni, L., Nesi, G., Bersanelli, M., Buti, S., De Giorgi, U., Galli, L., Sbrana, A., Conca, R., Carella, C., Naglieri, E., Pignata, S., Procopio, G., Antonuzzo, L.

مصطلحات موضوعية: fourth-line therapy, immune checkpoint inhibitor, metastatic renal cell carcinoma, targeted therapy, tyrosine kinase inhibitor, vascular endothelial growth factor receptor

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35312175; info:eu-repo/semantics/altIdentifier/wos/WOS:000770847900001; journal:CANCER MEDICINE; https://hdl.handle.net/11573/1641667Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85126550504

الإتاحة: https://doi.org/10.1002/cam4.4681Test
https://hdl.handle.net/11573/1641667Test